Italia markets closed

Takeda Pharmaceutical Co Ltd (TKD.MU)

Munich - Munich Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
24,500,00 (0,00%)
Alla chiusura: 08:05AM CEST
Schermo intero
Caricamento grafico interattivo in corso...
  • GlobeNewswire

    HUTCHMED Announces Submission of New Drug Application for Fruquintinib for Previously Treated Metastatic Colorectal Cancer in Japan

    — Third major market authorization application based on data from the FRESCO-2 global Phase III trial —HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Sept. 29, 2023 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (Nasdaq/AIM:​HCM, HKEX:​13) (“HUTCHMED”) today announced that Takeda (TSE:4502/​NYSE:TAK) has submitted a New Drug Application (“NDA”) to the Ministry of Health, Labour and Welfare (“MHLW”) in Japan for the approval of fruquintinib for the treatment of adult patients with previously